NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC

Insider Sentiment (TTM):

Last Purchase:2026-03-01Last Sale:2026-03-30Shares Purchased (TTM):1,000,000Shares Sold (TTM):47,572

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:11,604,041Shares Outstanding:8,484,926Institutional Ownership Pct.:136.76%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Assets
Cash And Cash Equivalents At Carrying Value	2	3	4	7	8	1	1	1	2	2	3	5
Accounts Receivable Net Current	1	2	3	1	-	0	2	0	0	1	1	-
Inventory Net	2	2	2	2	2	2	2	3	2	1	2	2
Deferred Offering Costs	0	0	0	0	-	0	0	0	-	-	-	-
Prepaid Expense And Other Assets Current	-	-	-	-	-	-	0	0	0	0	0	0
Prepaid Expense Current	0	0	0	0	0	0	-	0	-	-	-	0
Assets Current	6	7	8	10	10	4	6	5	4	5	5	7
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	1	1
Assets	6	8	9	11	11	4	6	5	5	5	6	8
Liabilities Current
Liabilities And Stockhold…
Accounts Payable Current	1	1	1	1	0	1	1	1	1	1	1	1
Accrued Liabilities And Other Liabilities	1	1	1	1	1	1	-	1	-	-	-	-
Liabilities Current	2	2	1	2	1	2	2	2	2	2	1	2
Derivative Liabilities Noncurrent	-	-	-	-	1	1	2	2	-	-	-	-
Warrants And Rights Outstanding	0	1	1	1	-	-	-	2	-	-	-	-
Accrued Liabilities Current	-	-	-	1	-	-	1	1	1	1	1	1
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	-	0	0
Liabilities	2	2	2	4	3	3	4	5	2	2	1	2
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	88	87	86	86	85	77	76	76	75	73	70	69
Retained Earnings Accumulated Deficit	-84	-82	-80	-79	-77	-75	-73	-75	-72	-69	-66	-63
Stockholders Equity	4	5	6	7	8	1	3	1	3	4	4	6
Liabilities And Stockholders Equity	6	8	9	11	11	4	6	5	5	5	6	8
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	9	9	8	8	8	5	5	5	5	4	4	4
Shares Outstanding	9	9	8	8	8	5	5	5	5	4	4	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	10.60%	7.81%	16.84%	-21.64%	-31.66%	-61.28%	-	-	-	-	-	-
2025	-11.96%	-57.59%	-44.11%	-9.63%	8.85%	17.70%	-4.46%	12.05%	-4.58%	31.14%	16.77%	26.20%
2024	-14.18%	-12.06%	-17.02%	-27.28%	-29.47%	-41.93%	6.07%	29.28%	26.86%	42.98%	35.27%	24.65%
2023	-	-	-	-	-	-	-16.32%	-19.34%	-19.16%	0.65%	-8.50%	-20.26%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.84	4.21	6.41	4.44	7.13	2.13	3.64	2.09	2.42	3.06	3.68	4.08
Quick Ratio	1.56	2.80	4.96	3.41	5.64	0.97	2.28	0.80	1.20	1.94	2.33	2.97
Working Capital	3.75M	5.42M	6.81M	7.92M	8.74M	1.99M	4.14M	2.42M	2.39M	3.17M	3.71M	5.52M
Leverage & Debt
Debt to Equity	0.64	0.49	0.34	0.53	0.32	2.96	1.21	5.53	0.63	0.40	0.32	0.30
Debt Ratio	0.39	0.33	0.25	0.34	0.24	0.75	0.55	0.85	0.39	0.29	0.24	0.23
Efficiency & Turnover
Asset Turnover TTM	1.11	1.53	1.16	1.13	0.84	1.17	0.93	0.51	0.74	0.59	0.36	0.19
Days Sales Outstanding TTM	42.36	44.00	105.34	28.92	-	27.71	92.44	18.67	38.20	37.69	41.40	-
Receivables Turnover TTM	8.62	8.30	3.47	12.62	-	13.17	3.95	19.55	9.55	9.68	8.82	-
Per Share Metrics
Diluted EPS TTM	-0.85	-0.82	-0.81	-0.54	-0.66	-1.27	-1.40	-2.76	-2.65	-2.96	-3.37	-3.93
Free Cash Flow Per Share TTM	-0.83	-0.89	-0.75	-0.44	-0.50	-0.96	-1.38	-2.50	-2.50	-2.80	-3.40	-4.39
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	55.65%	54.41%	54.87%	56.51%	56.63%	54.19%	47.66%	31.27%	28.87%	29.36%	26.11%	23.38%
Operating Profit Margin TTM	-83.43%	-80.10%	-87.71%	-46.46%	-85.56%	-114.25%	-118.02%	-344.26%	-311.92%	-347.54%	-481.67%	-612.32%
Net Profit Margin TTM	-78.63%	-75.50%	-78.34%	-39.63%	-80.51%	-114.67%	-125.02%	-356.74%	-308.54%	-343.58%	-478.48%	-607.42%
Growth Metrics
Net Revenue Growth (1Y)	42.84%	59.61%	51.60%	163.47%	69.00%	54.53%	104.21%	76.86%	206.58%	446.75%	1,017.27%	1,040.65%
Net Income Growth (1Y)	39.51%	5.10%	-5.00%	-70.73%	-55.90%	-48.43%	-46.64%	3.87%	19.84%	36.36%	50.94%	70.85%
EPS Growth (1Y)	30.48%	-35.78%	-41.79%	-80.49%	-75.18%	-57.04%	-58.48%	-29.67%	-22.98%	-13.61%	2.10%	50.84%
Valuation Metrics
P/E TTM	-3.54	-5.70	-5.59	-9.90	-6.17	-4.00	-3.54	-2.15	-1.81	-2.43	-2.81	-1.36
P/B TTM	6.99	7.79	5.96	5.05	4.03	23.49	8.68	32.24	7.27	8.07	8.58	2.58
P/S TTM	2.78	4.30	4.38	3.92	4.97	4.59	4.43	7.67	5.58	8.35	13.47	8.26
Market Cap	26.33M	39.56M	38.16M	35.70M	32.95M	26.44M	25.48M	26.50M	21.89M	31.10M	37.92M	16.13M
Enterprise Value	24.28M	36.75M	34.60M	29.13M	24.91M	25.12M	24.34M	25.04M	20.27M	28.66M	35.24M	10.81M
Calculated Values
Free Cash Flow TTM	-7.16M	-7.57M	-6.26M	-2.92M	-4.09M	-4.95M	-7.10M	-11.13M	-11.39M	-12.09M	-13.61M	-13.27M
Net Debt	-2.05M	-2.80M	-3.56M	-6.57M	-8.04M	-1.32M	-1.13M	-1.46M	-1.62M	-2.43M	-2.68M	-5.32M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-30Sale

Owner: Christianson, Mark

Title: Business Development Director

Shares: 15,363

Price/Share: $0.74

Value: $11,368.62

Shares Owned: 198,920

Relationship: Officer

Ownership: Direct

2026-03-13Sale

Owner: Christianson, Mark

Title: Business Development Director

Shares: 100

Price/Share: $0.80

Value: $80.00

Shares Owned: 214,283

Relationship: Officer

Ownership: Direct

2026-03-11Sale

Owner: Christianson, Mark

Title: Business Development Director

Shares: 2,109

Price/Share: $0.80

Value: $1,687.20

Shares Owned: 215,200

Relationship: Officer

Ownership: Direct

2026-03-01Purchase

Owner: Wambeke, David J.

Title: Chief Business Officer

Shares: 1,000,000

Price/Share: $0.67

Value: $670,000.00

Shares Owned: 1,000,000

Relationship: Officer

Ownership: Direct

2025-09-05Sale

Owner: Christianson, Mark

Title: Business Development Director

Shares: 30,000

Price/Share: $0.74

Value: $22,200.00

Shares Owned: 231,238

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-30	Christianson, Mark	Officer	Business Development Director	Direct	Sale	15,363	0.74	$11,368.62	198,920	4
2026-03-13	Christianson, Mark	Officer	Business Development Director	Direct	Sale	100	0.80	$80.00	214,283	4
2026-03-11	Christianson, Mark	Officer	Business Development Director	Direct	Sale	2,109	0.80	$1,687.20	215,200	4
2026-03-01	Wambeke, David J.	Officer	Chief Business Officer	Direct	Purchase	1,000,000	0.67	$670,000.00	1,000,000	4
2025-09-05	Christianson, Mark	Officer	Business Development Director	Direct	Sale	30,000	0.74	$22,200.00	231,238	4
2025-06-04	Christianson, Mark	Officer	Business Development Director	Direct	Sale	10,000	0.58	$5,800.00	261,491	4
2025-05-22	Christianson, Mark	Officer	Business Development Director	Direct	Sale	8,967	0.62	$5,559.54	271,491	4
2025-05-20	Christianson, Mark	Officer	Business Development Director	Direct	Sale	3,013	0.66	$1,988.58	280,472	4
2025-04-04	Mcclurg, Ronald W.	Officer	Chief Financial Officer	Direct	Purchase	200,000	0.50	$100,000.00	444,117	4
2025-04-04	Rosa, David A	Director,Officer	CEO and President	Direct	Purchase	100,000	0.50	$50,000.00	1,161,289	4
2024-06-06	Christianson, Mark	Officer	Business Development Director	Direct	Sale	2,189	0.88	$1,926.32	295,035	4
2024-06-05	Christianson, Mark	Officer	Business Development Director	Direct	Sale	25,800	0.88	$22,704.00	297,224	4
2023-12-27	Christianson, Mark	Officer	Business Development Director	Direct	Sale	31,445	1.46	$45,909.70	300,594	4
2023-12-22	Christianson, Mark	Officer	Business Development Director	Direct	Sale	1,800	1.40	$2,520.00	338,887	4
2023-12-21	Volker, Christopher	Officer	Chief Operating Officer	Direct	Purchase	75,000	1.40	$105,000.00	75,000	4
2023-09-13	Mcclurg, Ronald W.	Officer	Chief Financial Officer	Direct	Purchase	50,900	0.98	$49,882.00	130,400	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

136.76%

Inst. Shares: 11,604,041

Shares Outstanding: 8,484,926

2025-12-31

146.03%

Inst. Shares: 12,251,864

Shares Outstanding: 8,390,204

2025-09-30

211.74%

Inst. Shares: 14,172,966

Shares Outstanding: 6,693,484

2025-06-30

177.08%

Inst. Shares: 14,348,086

Shares Outstanding: 8,102,453

2025-03-31

22.50%

Inst. Shares: 1,166,667

Shares Outstanding: 5,185,075

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	11,604,041	8,484,926	136.76%
2025-12-31	12,251,864	8,390,204	146.03%
2025-09-30	14,172,966	6,693,484	211.74%
2025-06-30	14,348,086	8,102,453	177.08%
2025-03-31	1,166,667	5,185,075	22.50%
2024-12-31	1,166,667	5,140,615	22.70%
2024-09-30	1,200,000	4,461,291	26.90%
2024-06-30	3,505,990	4,559,688	76.89%
2024-03-31	4,140,257	4,319,277	95.86%
2023-12-31	4,137,022	4,000,068	103.42%
2023-09-30	3,967,932	3,020,789	131.35%
2023-06-30	1,434,866	2,930,398	48.96%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — SEC Financial Statements & Analysis

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) is a surgical & medical instruments & apparatus company, incorporated in DE. NEUROONE MEDICAL TECHNOLOGIES Corp trades on Nasdaq as: NMTC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NEUROONE MEDICAL TECHNOLOGIES Corp reported a 42.84% year-over-year revenue growth, a Gross Profit Margin of 55.65% (TTM), a Debt-to-Equity ratio of 0.64x, a Price-to-Sales (P/S) ratio of 2.78x (TTM), a Price-to-Book (P/B) ratio of 6.99x (TTM), at a market cap of $26.33M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 42.84%
Gross Profit Margin TTM: 55.65%
Debt To Equity: 0.64x
P/S TTM: 2.78x
P/B TTM: 6.99x
Market Cap: $26.33M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NEUROONE MEDICAL TECHNOLOGIES Corp in?

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) operates in the Surgical & Medical Instruments & Apparatus industry.

What is NMTC's market cap?

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) has a market capitalization of $26.33M as of 2026-06-30.

What exchange does NMTC trade on?

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) trades on the Nasdaq.

Where is NEUROONE MEDICAL TECHNOLOGIES Corp incorporated?

NEUROONE MEDICAL TECHNOLOGIES Corp is incorporated in DE.